Are public-private partnerships set to be drivers of innovation across the pharmaceutical industry? Read to find out more.

Non-adherence to medication can be caused by a range of factors, including unconscious biases. How can pharma rework current models to ensure they are connecting with patients?

Read the article to find out what action the pharma industry has taken to help Ukraine during the conflict.

Antimicrobial resistance poses a significant threat to human health worldwide, with inconceivable consequences. Is pharma doing enough?

Claus Zieler, President of Established Markets at Astellas, speaks about the role leaders play in cultivating an enticing company culture

Brazil has consistently appeared in the top 10 global pharmaceutical markets over the last decade and is making steady progress.

The first-time launch landscape is growing. In an increasing number of cases, it’s emerging biopharma and biotech companies launching new drugs rather than established pharma giants leading the way.

Reverse mentoring challenges the status quo and flips traditional learning dynamics on their axis. This how-to guide deconstructs what must be considered when building a reverse mentoring scheme in pharma.